Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Sarepta Therapeutics, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
www.sarepta.comAI Executive Summary
AI-powered analysis of 8-K filing content
Sarepta Therapeutics settled patent infringement litigations with REGENXBIO, UPenn, and Catalent on September 23, 2026, resolving disputes over two U.S. patents with a $39 million charge, reducing legal uncertainty and allowing the company to move forward operationally.
Key Takeaways
Settlement resolves pending patent infringement litigations and appeals involving U.S. Patent Nos. 11,680,274 and 10,526,617
Sarepta recorded a $39.0 million litigation contingency charge to cover the settlement obligations
2 more takeaways
Filing Overview
What This Means
Sarepta Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.